Lombard Odier Asset Management (Europe) LTD Exact Sciences Corp Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $47,190 - $70,770	-1,000 Reduced 16.67%	5,000 $339,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $60,700 - $106,300	-2,000 Reduced 25.0%	6,000 $297,000
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $284,880 - $609,840	8,000 New	8,000 $315,000

Others Institutions Holding EXAS

# of Institutions

676

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.03 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$916 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$828 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$697 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$386 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account